The MNKD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MNKD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The MNKD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View MNKD Detailed Price Forecast - CNN Money | View MNKD Detailed Summary - Google Finance | ||
View MNKD Detailed Summary - Yahoo! Finance | View MNKD Stock Research & Analysis - Zacks.com |
View MNKD Trends & Analysis - Trade-Ideas | View MNKD Major Holders - Barrons | ||
View MNKD Call Transcripts - NASDAQ | View MNKD Breaking News & Analysis - Seeking Alpha | ||
View MNKD Annual Report - CompanySpotlight.com | View MNKD OTC Short Report - OTCShortReport.com | ||
View MNKD Fundamentals - TradeKing | View MNKD SEC Filings - Bar Chart | ||
View Historical Prices for MNKD - The WSJ | View Performance/Total Return for MNKD - Morningstar | ||
View the Analyst Estimates for MNKD - MarketWatch | View the Earnings History for MNKD - CNBC | ||
View the MNKD Earnings - StockMarketWatch | View MNKD Buy or Sell Recommendations - MacroAxis | ||
View the MNKD Bullish Patterns - American Bulls | View MNKD Short Pain Metrics - ShortPainBot.com |
View MNKD Stock Mentions - StockTwits | View MNKD Stock Mentions - PennyStockTweets | ||
View MNKD Stock Mentions - Twitter | View MNKD Investment Forum News - Investor Hub | ||
View MNKD Stock Mentions - Yahoo! Message Board | View MNKD Stock Mentions - Seeking Alpha |
View Insider Transactions for MNKD - SECform4.com | View Insider Transactions for MNKD - Insider Cow | ||
View MNKD Major Holdings Summary - CNBC | View Insider Disclosure for MNKD - OTC Markets | ||
View Insider Transactions for MNKD - Yahoo! Finance | View Institutional Holdings for MNKD - NASDAQ |
View MNKD Stock Insight & Charts - FinViz.com | View MNKD Investment Charts - StockCharts.com | ||
View MNKD Stock Overview & Charts - BarChart | View MNKD User Generated Charts - Trading View |
MannKind Announces CFO Transition
Posted on Tuesday March 26, 2024
Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through December 31, 2024Christopher Prentiss appointed Chief Financial Officer, effective April 22, 2024 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lu
Jim Cramer Says You Should Avoid These 11 Stocks
Posted on Monday March 25, 2024
In this article, we will take a detailed look at Jim Cramer Says You Should Avoid These 11 Stocks. For a quick overview of such stocks, read our article Jim Cramer Says You Should Avoid These 5 Stocks. Jim Cramer in his latest program took a jab at the Department of Justice and Washington authorities in general, calling regulators […]
INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps
Posted on Monday March 11, 2024
Post-meal hyperglycemia was significantly reduced by 20% with inhaled insulin compared with rapid-acting insulin delivered through MDI or insulin pumpsSubjects utilizing inhaled insulin experienced a 22% decrease in mean glucose excursions in the first two hours compared to the standard of care17-week primary endpoint results will be presented during a 90-minute symposium at the American Diabetes Association’s Scientific Sessions in June DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 11, 202
MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8
Posted on Tuesday March 05, 2024
Dr. Hirsch to present meal challenge results when switching from multiple daily injections (MDI) or insulin pumps to inhaled insulin (Afrezza® (insulin human) Inhalation Powder)DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that new clinical data from the I